Introduction {#sec1}
============

A pulse is transmitted to the periphery with each heartbeat, with propagation characteristics influenced by aging and/or cardiovascular disease. The pulse can be detected non-invasively using photoplethysmography (PPG), typically utilizing a near-infrared optical transducer to produce a signal associated with red blood cell changes in the tissue micro-vascular bed. PPG signals can be complex, and they have high-frequency (pulse shape; "AC") and low-frequency (e.g. vasomotion; "DC") components ([@ref21]; [@ref2]; [@ref1]). PPG characteristics are body site specific with differences reported in timing (pulse arrival time, PAT) ([@ref3],[@ref4]) and amplitude ([@ref19]; [@ref18]), as well as in their variability ([@ref20]; [@ref8]; [@ref6]).

Innovative multi-site PPG technology (MPPG) has been developed to study the circulation using peripheral pulse assessments from ear, thumb (finger), and great toe sites ([@ref2]). MPPG has shown value in the study of changes in pulse with aging ([@ref150]), peripheral arterial disease ([@ref5]; [@ref6]), connective tissue disease ([@ref17]), endothelial function ([@ref23]), and arterial stiffness ([@ref25]). Autonomic function assessment is also of great interest, including using PPG to track respiration rate ([@ref12],[@ref13]; [@ref22]). In normal healthy subjects breathing slowly and regularly, e.g., at 0.1 Hz, the heart rate and blood pressure can synchronize to this driving frequency ([@ref10]; [@ref14]; [@ref8]; [@ref7]; [@ref22]). PPG characteristics can also be modulated in this way ([@ref3],[@ref4]) but noting that only limited data have been published so far, i.e., relationship between finger pulse transit time and cardiac electrocardiogram (ECG) R-R interval changes ([@ref9]). As far as the author is aware, there have been no comparative published studies quantifying the phase relationships between simultaneous head-to-foot PPG pulse timing and amplitude changes and R-R interval changes, although such data could ultimately yield valuable information for cardiovascular system assessment. The primary aim of this pilot study was to quantify the correlation lags between MPPG pulse timing/amplitude changes and R-R interval changes under a standardized slow-paced breathing challenge.

Materials and Methods {#sec2}
=====================

Physiological Measurements {#sec3}
--------------------------

The MPPG system has been described previously for cardiovascular assessment ([@ref2]; [@ref1]). Briefly, PPG pulses were collected simultaneously from the right and left ear lobes and pads of thumbs/great toes using six matched PPG amplifiers (bandwidth 0.005--30.0 Hz). Reflection mode probes (Artema, Denmark: ear type 75331-9 with clip, thumb, and toe probes with black Velcro cuff 75333-5) were utilized. A single-lead diagnostic bandwidth ECG provided a cardiac timing reference.

Measurements were collected in a warm and comfortable vascular measurement facility (ambient temperature \~24°C) with subjects positioned supine. Following acclimatization, subjects were asked to perform a slow-paced breathing exercise (one breath every 10 s; inspiration:expiration 50:50) as visually directed by a triangular rolling waveform, with waveforms captured to computer (100 s, sampling rate 500 Hz). Participants had no known cardiovascular disease/arrhythmia. Waveforms were collected in 1999 from healthy staff/student volunteers with informed consent obtained in compliance with best practice at that time. This study is a secondary analysis of this previously collected anonymized data; their further consent was not essential for this study.

Waveform Analysis {#sec4}
-----------------

Waveforms were analyzed off-line (MATLAB v2012a, MathWorks) using digital signal processing stages of low/high pass filtering and landmark extraction, then quantification of beat-to-beat ECG R-R interval variation, pulse arrival time (to pulse foot; PATf), and pulse foot-to-peak amplitude (AMP; [Figure 1](#fig1){ref-type="fig"}). Analysis was semi-automated and included a manual quality checking stage to allow editing of pulses with poor automatically recognized landmarks. The checked beat-to-beat R-R intervals, PATf, and AMP data were resampled using simple interpolation (resolution 1/100^th^ of a heartbeat). Two sets of analysis were performed: cross correlation and the quantification of PATf and R-R interval variability.

![Example ECG and single-site PPG waveforms with key analysis landmarks PATf and AMP identified. PATf and AMP values on a beat-to-beat basis are also determined for the other five body sites of the six-channel MPPG pulse measurement system.](fphys-10-01190-g001){#fig1}

### Cross Correlation Analysis {#sec5}

MATLAB-based cross correlation analysis determined the delays, i.e., correlation lags between PATf changes and AMP changes for each of the six body measurement sites, relative to R-R interval variation, during slow-paced breathing. The first clear correlation lag peak per body site was semi-automatically determined from cross correlation data for PATf and also for AMP using plots in up to a 12-beat window, measured in beats. Clearly irregular cross correlation plots were excluded.

### PATf and R-R Interval Timing Variability Analysis {#sec6}

Standard deviations (SDs) for site PATf changes were determined (SD-PATf: Ears; Thumbs; Toes). In addition, normalized variability was also calculated for each site using SD-PATf divided by the cardiac timing reference SD of R-R interval variability (SD-RR) over the same measurement period.

Statistical Analysis {#sec7}
--------------------

Minitab (V17) statistical software was utilized. Data were summarized using non-parametric, i.e., median \[interquartile range, (IQR)\] measures. Bilateral similarity for cross correlation data, timing variability between each of the three-pair body sites, and the segmental differences between sites (Ears-Thumbs; Ears-Toes; Thumbs-Toes) were tested using Wilcoxon's signed rank test. Unpaired data comparisons utilized the Mann-Whitney *U* test. Differences between segmental levels for PATf and AMP lags and for timing variability measures were assessed using Kruskal-Wallis test. Standard linear regression tested for significant associations of age with correlation/timing measures. *p* \< 0.05 was considered statistically significant.

Results {#sec8}
=======

Eighteen healthy adult volunteers \[12 male, median age 35 (30--47) years\] participated. All could be included for the PATf correlation and normalized variability analyses, but two were excluded from the AMP analysis as their correlation plots could not be interpreted with confidence. Median (IQR) peak cross correlation levels between R-R intervals and PATf for Ears, Thumbs, and Toes were 0.55 (0.39--0.70), 0.62 (0.45--0.76), and 0.71 (0.60--0.75), respectively, and those levels between R-R intervals and AMP for Ears, Thumbs, and Toes were 0.61 (0.41--0.73), 0.34 (0.25--0.57), and 0.39 (0.22--0.51), respectively.

No significant differences were found between right and left PATf correlation lags for any segmental site ([Table 1](#tab1){ref-type="table"}), demonstrating bilateral similarity overall. There was also a tendency to bilateral similarity for the AMP lags for the Ears and Toes, although the right thumb was delayed relative to the left by 0.72 heartbeats (−0.17--1.64; *p* \< 0.05). PATf variability (SD-PATf) also showed bilateral similarity. Overall ranges for correlation lags and PPG variability (e.g., SD-PATf) normalized to R-R interval variability (SD-RR) are summarized in [Figures 2A](#fig2){ref-type="fig"}--[C](#fig2){ref-type="fig"}, using the mean of right and left body sides.

###### 

Summary of PATf and AMP cross correlation phase lag data (in heartbeats) and also normalized variability data for the 0.1 Hz paced breathing exercise.

                                                                           Right body side        Left body side         *p*
  ------------------------------------------------- ---------------------- ---------------------- ---------------------- -----
  **Correlation phase lags**                                                                                             
  PATf (beats)                                      Ears                   3.57 (2.90--3.82)      3.43 (2.82--4.29)      ns
  Thumbs                                            2.91 (2.00--3.85)      3.05 (2.07--3.75)      ns                     
  Toes                                              2.26 (1.74--2.89)      2.16 (1.81--2.80)      ns                     
  AMP (beats)                                       Ears                   6.85 (3.47--8.22)      5.69 (3.11--8.12)      ns
  Thumbs                                            6.53 (5.28--7.39)      5.49 (1.78--6.47)      p \< 0.05              
  Toes                                              7.09 (6.07--7.44)      6.69 (5.98--8.09)      ns                     
  **SD-PATf variability and normalized to SD-RR**                                                                        
  Variability (ms)                                  Ears                   4.3 (3.3--5.4)         4.9 (3.3--5.5)         ns
  Thumbs                                            4.5 (3.9--6.8)         4.4 (3.8--6.4)         ns                     
  Toes                                              7.4 (5.9--10.3)        7.4 (6.4--9.2)         ns                     
  Normalized                                        Ears                   0.054 (0.039--0.077)   0.057 (0.037--0.073)   ns
  Thumbs                                            0.062 (0.042--0.073)   0.056 (0.042--0.077)   ns                     
  Toes                                              0.099 (0.076--0.132)   0.094 (0.085--0.142)   ns                     

*The median phase lag values shown are all positive, i.e., the PPG measure lags the ECG R-R interval measure. Note: ns denotes non-significant*.

![Overall **(A)** PATf and **(B)** AMP correlation lags and **(C)** PATf timing variability normalized to cardiac changes (SD of PATf at each site normalized using the SD of R-R intervals). A positive cross correlation value, i.e., lag means changes in PPG measures lag behind changes in the ECG R-R interval measure during paced breathing.](fphys-10-01190-g002){#fig2}

There were significant differences overall in PATf correlation lags between segmental levels (*p* \< 0.01). These were the lowest for the Toes and with significant differences found between Thumbs and Toes \[Thumbs-Toes; +0.74 (−0.32--1.29) beats, *p* \< 0.05\] and between Ears and Toes \[Ears-Toes; +0.97 (0.53--1.39) beats, *p* \< 0.005\]. There were, however, no significant differences for AMP between the segmental levels. AMP correlation lags were significantly greater than for PATf at all sites (Ears, *p* = 0.01; Thumbs and Toes, both *p* \< 0.001).

Overall, there were significant differences between segmental levels for SD-PATf (*p* \< 0.001). Normalized variability was the largest at the Toes, and significant segmental differences were found between Ears and Toes \[Toes-Ears; 0.046 (0.018--0.069), *p* \< 0.001\] and between Thumbs and Toes \[Toes-Thumbs; 0.047 (0.012--0.059) beats, *p* \< 0.001\] but non-significant for the comparison of Ears-Thumbs. RR interval variability (SD-RR) was 79.1 (54.6--106.5) ms, which significantly decreased with age (*r* = −0.62; *p* \< 0.01), but only the Toes normalized variability changed significantly, i.e., increasing with age (*r* = +0.54; *p* \< 0.05). Age-related associations were not found for correlation lag at any site, although PATf peak correlation levels decreased at proximal sites with age \[ears (*p* \< 0.01); Thumbs (*p* \< 0.05)\]. No significant differences were found between male and female subjects.

Discussion {#sec9}
==========

Cross correlation and variability data have been obtained for MPPG head-to-foot pulse measurements plus ECG during a slow, i.e., 0.1 Hz paced breathing exercise. Previous published MPPG work has shown the tendency to bilateral similarity in healthy subjects across the age ranges in the case of "static" pulse arrival (transit) time and shape. This study has extended the knowledge on PPG by quantifying the relative changes and variability between head-to-foot peripheral sites under this breathing challenge. In healthy subjects, the cross correlation derived delays have the tendency to bilateral similarity, specific segmental level differences, and with differences between the pulse timing and amplitude characteristics.

The key study by [@ref9] reported a mean (SD) delay between pulse timing changes and R-R interval changes of 3.17 (0.76) beats for the single-finger site studied. Corresponding results from this study are consistent but by using MPPG the PATf data add value to show that correlation lags appear to be the shortest for the toes (greatest for the ears). In addition, it has been noted that overall pulse amplitude correlation lags are significantly higher than for PATf. The reasons for the segmental site differences observed are currently unclear but certainly warrant further assessment in both healthy subjects and cardiovascular patients. It may be that the different correlation lags across body sites may be due to the different origins of the PPG variability: autonomic nervous system (sympathetic in toes and fingers and both sympathetic and parasympathetic in ears) and two mechanical effects, which might differently affect lower and upper body sites ([@ref24]). The degree of variability in pulse under slow-paced breathing has also demonstrated a tendency to bilateral similarity and segmental differences, e.g., with toe site having the largest overall normalized variability. It is possible that this could link to regional differences in sympathetic tone and/or blood vessel compliance. It would be very interesting next to apply the techniques to the study of whole body blood pressure control and cardiovascular coupling. The reducing peak correlation levels with age for proximal site PATf relative to R-R should also be further investigated.

Other vascular optical technologies have been utilized for studying head-to-foot low frequency oscillations under paced breathing, including multi-channel near-infrared spectroscopy ([@ref15]). They also found a tendency to bilateral similarity/segmental differences with delays in signals of up to several seconds. The optical technique though studied oxyhemoglobin concentration fluctuations rather than beat-to-beat perfusion with MPPG. There is scope though for future sensor development allowing the parallel assessment of spectroscopy and PPG to take forward in different patient groups. Peak cross correlation level differences between sites and between pulse measures have also been shown -- information which could help inform sensor design for respiration rate/blood pressure tracking with PPG based wearable sensors. There are many exciting developments in PPG technology, including MPPG variants, wearable sensors, and non-contact imaging photoplethysmography (iPPG; [@ref26]), which could be used to explore regional signal variations across the body with paced breathing challenges.

Limitations of Study {#sec10}
--------------------

Limited demographic data were collected in this pilot -- a larger future study should include full demographics to allow appropriate multivariate analyses to be performed; more data from females would help give confidence so that the test is not underpowered for assessing gender differences; cross correlation is a linear function and can be limited in locating phase lags between two time series interacting in a closed loop, and thus, the MPPG signal analysis could benefit from using non-linear techniques ([@ref11]). Future works should also assess measurements from a larger group of normals across the age ranges and explore these with assessments including arterial stiffness and vascular compliance. Furthermore, other novel signal processing approaches could be explored, including: non-linear techniques based on corrected conditional entropy, identifying where MPPG measures are distributed in frequency (e.g., Mayer waves, respiration-induced oscillations), and alternative methods to estimate the gains between signal and variability measures ([@ref16]; [@ref11]). Data sets could also be collected to contrast a range of breathing frequencies to explore variability magnitude/phase effects between PPG and ECG. Ultimately, we will need to compare normative data sets with cardiovascular patient groups, including patients with diabetes and/or dementia where autonomic and vascular function can be impaired.

Conclusion {#sec11}
==========

Innovative multi-site photoplethysmography technology has been utilized in this pilot study to characterize the delays for changes in head-to-foot PPG pulse timing/amplitude characteristics relative to ECG R-R interval under slow-paced breathing. The study has confirmed a tendency to bilateral similarity plus segmental differences. Cross correlation and variability data are now available for comparison with cardiovascular patient groups to further support the development of novel autonomic function assessment techniques.
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